Overdose RADAR Act
- Sponsor
- Sen. Scott, Rick [R-FL]
- Committees
- Health, Education, Labor, and Pensions Committee (primary)
- Last action
- Feb 24, 2025
Bottom line
The Overdose RADAR Act proposes a multi-faceted federal strategy to address the fentanyl crisis by enhancing data collection, improving interagency coordination, expanding harm reduction measures, and empowering schools to respond to overdoses.
What it actually does
This bill, known as the "Overdose RADAR Act," aims to combat the fentanyl crisis through several key initiatives. It authorizes grants for states and localities to improve data collection on opioid-related overdoses, reforms the Office of National Drug Control Policy (ONDCP) to enhance coordination and data standardization, and expands State Opioid Response (SOR) grants to include best practices. Additionally, it establishes a pilot program for wastewater analysis to detect illicit substances, authorizes grants for schools to administer overdose reversal drugs, and explicitly excludes fentanyl test strips from the definition of drug paraphernalia.
Proponents argue
Proponents argue that the bill provides essential tools to combat the escalating fentanyl crisis by improving the accuracy and comprehensiveness of overdose data, which is critical for effective policy-making. They contend that empowering schools with overdose reversal medications and making fentanyl test strips legal will save lives through proactive prevention and rapid response. Furthermore, strengthening ONDCP's role and fostering interagency collaboration will lead to a more unified and efficient federal response.
Opponents contend
Critics may raise concerns about potential federal overreach into state and local matters, particularly regarding the guidance for classifying overdose deaths as homicides, which could have unintended legal and social consequences. Some may also express reservations about the privacy implications of expanded data collection and wastewater surveillance. Additionally, some opponents of harm reduction strategies might argue that legalizing fentanyl test strips could be perceived as condoning drug use rather than deterring it.
The bill is relatively short and clearly structured, making it accessible for an informed reader to understand its provisions within a reasonable timeframe.
Section 2, Part D of title V of the Public Health Service Act (42 U.S.C. 290dd et seq.), adding Sec. 554.
Opioid Overdose Data and Surveillance Grants
This provision authorizes the Secretary of Health and Human Services to award grants to states, territories, and localities. These grants are intended to support activities that improve data and surveillance related to opioid-related overdoses. Specific activities include enhancing postmortem toxicology testing, linking data across different systems, improving electronic death reporting, and making data on both fatal and nonfatal opioid overdoses more comprehensive.
Supporters argue
Proponents argue that accurate and comprehensive data is the foundation for effective public health interventions and policy development to combat the opioid crisis. They contend that these grants will address critical gaps in current surveillance systems, allowing for a more precise understanding of overdose trends and impacts.
Critics contend
Some critics might express concerns about the administrative burden placed on states and localities to apply for and manage these grants, as well as the potential for data privacy issues with increased data linkage across systems. They may also question the cost-effectiveness of these data improvements compared to direct intervention programs.
Tradeoffs
The provision balances the critical need for robust public health data with potential concerns regarding data privacy, the administrative burden on state and local entities, and the allocation of resources between data collection and direct intervention services.
Section 3
Office of National Drug Control Policy (ONDCP) Reform and Data Coordination
This section includes a Sense of Congress that the ONDCP Director should hold a Cabinet-level position. It mandates ONDCP to develop strategies to prevent duplication of services among National Drug Control Program agencies and to collaborate with the National Center for Health Statistics and the National Forensic Laboratory Information System to establish national data submission standards, including data from guilty pleas. Furthermore, ONDCP is directed to issue guidance encouraging states and localities to classify overdose deaths as homicides if not self-induced and intentional. It also modifies ONDCP's authority regarding Congressional Review Act submissions and reprogramming requests.
Section 4, Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee-3a).
Enhanced Reporting and Best Practices for State Opioid Response (SOR) Grants
This section amends the 21st Century Cures Act to require recipients of State Opioid Response (SOR) grants to include an assessment of challenges in addressing opioid and stimulant misuse and use disorders, accounting for variations in how grant funds are implemented. Additionally, it mandates that the Secretary of Health and Human Services provide best practices on how to address opioid-related overdoses, in addition to the existing technical assistance provided to grant recipients.
Section 5
Illicit Substance Wastewater Analysis Pilot Program
This section directs the Director of the Centers for Disease Control and Prevention (CDC), in collaboration with the Attorney General, to establish a 3-year pilot program. This program will award competitive grants to municipal wastewater treatment facilities. The purpose of these grants is to fund wastewater analysis to determine the prevalence of specific illicit substances, such as fentanyl or xylazine, in the communities served by these facilities.
Sections 6 and 7, amending Sections 544 and adding 544A of the Public Health Service Act (42 U.S.C. 290dd-3).
Opioid Overdose Response and Prevention in Elementary and Secondary Schools
This bill expands existing grants for reducing opioid overdose deaths to include the 'administering' of drugs, not just 'prescribing.' More significantly, it authorizes new grants for eligible entities to implement programs in public and private elementary and secondary schools, allowing trained personnel to administer drugs and devices for emergency treatment of known or suspected opioid overdoses. To receive these grants, schools must certify they have a program in place, maintain a supply of drugs/devices, have trained personnel available during operating hours, and that the state attorney general certifies adequate civil liability protection for these personnel.
Section 8, Section 422(f) of the Controlled Substances Act (21 U.S.C. 862(f)).
Decriminalization of Fentanyl Test Strips
This section amends the Controlled Substances Act to explicitly exclude fentanyl test strips from the definition of 'drug paraphernalia.' This change means that fentanyl test strips would no longer be considered illegal under federal law, removing a barrier to their distribution and use as a harm reduction tool.
Requires the Office of National Drug Control Policy (ONDCP) to collaborate with the National Center for Health Statistics and the National Forensic Laboratory Information System to create national standards for the submission of data, specifically including data from cases in which the defendant pleads guilty.
Section 3(b)(2)
Why it matters:This is likely standard legislative practice for specifying data collection parameters within a broader mandate for data standardization, rather than an attempt to conceal.
Case for: Proponents argue that including data from guilty pleas provides a more comprehensive understanding of drug-related criminal activity and its public health implications, offering insights into the full scope of the fentanyl crisis that might otherwise be missed.
Case against: Critics might raise concerns about the privacy implications of collecting and standardizing data from guilty pleas, and how this data might be used or linked, potentially impacting individuals' rights or creating new surveillance challenges.
Estimated impact: Significantly expands the scope of federal drug-related data collection, potentially influencing criminal justice and public health policy.
Directs the Office of National Drug Control Policy (ONDCP) to issue guidance that States and localities should record overdose deaths as homicides if there is sufficient evidence that the overdose was not self-induced and intentional.
Section 3(b)(3)
Why it matters:This phrasing as 'guidance' rather than a direct mandate might be intended to navigate federalism concerns while still pushing for a significant policy shift. It's a common legislative technique to suggest strong federal preferences without imposing a direct, enforceable mandate.
Case for: Proponents argue that classifying overdose deaths caused by illicit substances as homicides, when evidence supports it, will increase accountability for drug traffickers and dealers, potentially deterring the distribution of deadly drugs and providing justice for victims' families.
Case against: Critics contend that this guidance could lead to the over-criminalization of drug-related deaths, potentially misclassifying deaths that are more accurately described as accidental or suicides. They argue it could divert resources from public health interventions towards criminal investigations and create legal complexities for medical examiners and law enforcement.
Estimated impact: Could significantly alter how overdose deaths are investigated and prosecuted in states and localities that adopt the guidance, potentially increasing criminal charges related to drug distribution.
Section 3(d) states that if ONDCP does not certify a final rule by a National Drug Control Program participant as consistent with National Drug Control Policy, the rule is deemed submitted under the Congressional Review Act (CRA). Section 3(e) amends the ONDCP Reauthorization Act of 1998 to change 'deemed approved' to 'deemed denied' for certain reprogramming and transfer requests.
Section 3(d) and (e)
Why it matters:These are technical adjustments to ONDCP's oversight and administrative powers, which are typically found in the fine print of legislative text. They are not intended to be prominent policy changes but rather operational refinements.
Case for: Proponents argue these changes strengthen ONDCP's oversight authority, ensuring that federal agencies' actions align with the National Drug Control Policy and providing Congress with more control over agency reprogramming requests, thereby enhancing accountability and coordination.
Case against: Critics might argue that these provisions could grant ONDCP excessive power over other federal agencies, potentially slowing down or complicating necessary administrative actions and rule-making processes. The 'deemed denied' provision could create unnecessary bureaucratic hurdles.
Estimated impact: Increases ONDCP's administrative and oversight power over other federal agencies involved in drug control, potentially impacting the efficiency of agency operations and rule-making.